Why Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson is one of the top broker picks in the Dow. More 

63 Trades to Kick Off the Week

During these busy times, it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start. More 

The Long Trail Back For the Energy Sector

Kinder Morgan's recent move to cut its dividend signals a start to a long road back for the energy sector More 

One Put and One Call Option Play for Pfizer (PFE)

Investors in Pfizer saw new options become available today for the January 2016 expiration. Here is one put and one call play for PFE stock More 

5 Big Pharma Stocks to Buy (And 2 Busts to Avoid!)

Several Big Pharma names are worthy buys right now, but a couple of pharmaceutical stocks may be best left avoided. More 

Wall Street Slides Lower in Pre-Holiday Trading

Stocks moved lower on Wall Street today, with consumer staples leading the way and telecom bringing up the rear. Crude saw some overnight volatility, while Pfizer made headlines with an inversion deal with Allergan. More 

Market Underestimates Pfizer Stock After Allergan Deal

Pfizer stock has been falling on rumors, and then official reports, of a buyout of Allergan, but there's no real downside to this pairing. More